Genetic testing should be linked to an explicit plan for diagnosis, gene-informed risk assessment, phenotype-directed care, and family follow-up, to examine how molecular findings inform clinical care.
Current evidence from test selection to genetic counseling, management of relatives when only a variant of uncertain significance is identified, surveillance of genotype-positive, phenotype-negative relatives, psychosocial impact and shared responsibility for recontact after reclassification are summarized.
Iuliana Maria Zaharia, S. A. Rițiu, Norbert Wellmann et al.· Genes· 0 citations
PURPOSE OF REVIEW
Genetic information is increasingly relevant across the lung transplant continuum. A molecular diagnosis of the recipient's native lung disease can refine candidate evaluation, identify extrapulmonary vulnerability, guide family counseling, and anticipate posttransplant complications. Pharmacogenetic...
Ram R. Katpally, T. Pena, Julia Klesney-Tait· Current Opinion in Organ Tra...· 0 citations
Pulmonary hypertension (PH) may complicate a broad range of genetic syndromes beyond the established spectrum of heritable pulmonary arterial hypertension. Although these conditions are individually rare, together they represent an emerging field at the crossroads of developmental biology, vascular medicine, and precis...
Julien Grynblat, F. Coulet, T. Lacoste-Palasset et al.· European Respiratory Journal· 0 citations
Using LCA, distinct phenogroups within PAH-CHD were identified with varying clinical profiles, long-term survival, and treatment responses, which may help to refine prognostic assessments and treatment strategies.
Q. Li, Q. Yu, G.-Z. Zhang et al.· European Heart Journal· 0 citations
IPH demonstrated the most severe hemodynamic impairment, CTEPH showed intermediate severity, and CTD-APAH exhibited milder pulmonary pressures but more substantial functional limitation, while CTEPH showed intermediate hemodynamic impairment, while CTD-APAH displayed comparatively milder pulmonary pressures but a predo...
C. Hjalmarsson, E. Bollano, S. Bartfay et al.· European Heart Journal· 0 citations
Advanced prenatal imaging and chromosomal microarray have improved detection of fetal anomalies, yet many structurally abnormal fetuses remain without a unifying diagnosis. This manuscript describes representative prenatal cases evaluated with genome sequencing (GS) or exome sequencing (ES), demonstrating how genomic d...
M. Bunnell, Briana O'Leary· American Journal of Medical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.